Federal award (DELIVERY ORDER, fiscal year 2022)
Recipient: DMS PHARMACEUTICAL GROUP INC
Awarding agency: Department of Defense / Defense Logistics Agency
Funding agency: Department of Defense / Defense Logistics Agency
Period of performance: 2023-03-20 to 2023-03-21
Current total value of award: $459.51
Description: 4560308652!ENGERIX-B PEDI 10 MCG/0.5 SYRN